PLATELET LUMIAGGREGATION TESTING: REFERENCE INTERVALS AND THE EFFECT OF ACETYLSALICYLIC ACID IN HEALTHY ADULTS
Abstract
Background: Light transmission aggregometry with lumiaggregometry are methods commonly recommended as a first-line test in platelet dysfunction diagnostic work-up. They are poorly standardized and usually performed in specialized laboratories. For proper interpretation, each laboratory should establish its own diagnostic approach in order to recognize abnormal aggregation patterns. The aim of this study was to measure plasma lumiaggregometry with basic agonists to establish the analyzer-reagent reference intervals (RI) for adults and to test the method response to aspirin.
Methods: The Chrono-Log Model 700 lumiaggregometer using Chrono-Par and Chrono-lume reagents (Chrono-Log Corp., Havertown, PA, USA) was used to measure the maximal aggregation and adenosine triphosphate release using adenosine diphosphate (2 mmol/L), collagen (2 mg/mL), arachidonic acid (1 mmol/L), epinephrine (5.5 mmol/L) and ristocetin (1.25 mg/mL), and thrombin (1 U/mL). The effect of aspirin on platelet aggregation and granule release was inspected.
Results: RIs derived from 40 healthy adults were calculated using the non-parametric approach. Wider intervals and low lower limits were determined for weak agonist as well as absence or impaired aggregation in up to one of 7 healthy controls. The response of platelets to aspirin shows response comparable to previously reported study.
Conclusions: Locally established RI in our study enable us to investigate platelet function in patients with a high probability of bleeding disorders. Values are agonist and equipment specific. The variability of the method can be reduced by considering standardized preanalytical and analytical variables. Pathological results must be interpreted in the context of other hemostasis test results and clinical findings.
References
Gresele P, for Subcommittee on Platelet Physiology of the International Society on Thrombosis and Hemostasis. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost 2015; 13: 314–22.
Gresele P, Falcinelli E, Bury L. Laboratory diagnosis of clinically relevant platelet function disorders. Int J Lab Hematol 2018; 40: Suppl 1: 34–45.
Hayward CPM, Moffat KA, Plumhoff E, Timleck M, Hoffman S, Spitzer E, et al. External quality assessment of platelet disorder investigations: results of international surveys on diagnostic tests for dense granule deficiency and platelet aggregometry interpretation. Semin Thromb Hemost 2012; 38: 622–31.
Hayward CPM, Moffat KA, Brunet J, Carlino SA, Plumhoff E, Meijer P, et al. Update on diagnostic testing for platelet function disorders: What is practical and useful? Int J Lab Hematol 2019; 41: Suppl 1: 26–32.
CLSI. Platelet Function Testing by Aggregometry; approved guideline. CLSI document H58-A. Wayne, PA: Clinical and Laboratory Standard Institute, 2008.
Hayward CPM, Moffat KA, Raby A, Israels S, Plumhoff E, Flynn G, et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol 2010; 134: 955–63.
Harrison P, Mackie I, Mumford A, Briggs C, Liesner R, Winter M, et al. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol 2011; 155: 30–44.
Cattaneo M, Cerletti C, Harrison P, Hayward CPM, Kenny D, Nugent D, et al. Recommendations for the Stan - 6 Trampu{ Bakija et al.: Platelet lumiaggregation testing: reference intervals dardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH. J Thromb Haemost 2013; 2013: 1183–9.
Yıkılmaz S¸A, Bakanay MS¸, Akinci S, Alisik M, Erel Ö, Dilek İ. Thiol-Disulphide Homeostasis In Essential Thrombocythemia Patients. J Med Biochem 2019; 38: 475–80.
Nieuwenhuis HK, Akkerman JW, Sixma JJ. Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood 1987; 70: 620–3.
Quiroga T, Goycoolea M, Matus V, Zúñiga P, Martínez C, Garrido M, et al. Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays. Br J Haematol 2009; 147: 729–36.
Badin MS, Graf L, Iyer JK, Moffat KA, Seecharan JL, Hayward CPM. Variability in platelet dense granule adenosine triphosphate release findings amongst patients tested multiple times as part of an assessment for a bleeding disorder. Int J Lab Hematol 2016; 38: 648–57.
CLSI. Define and Verify Reference Intervals in the Clinical Laboratory; approved guideline – third edition. CLSI document EP28A3c. Wayne, PA: Clinical and Laboratory Standard Institute; 2008.
Hayward CPM, Moffat KA, Pai M, Liu Y, Seecharan J, McKay H, et al. An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts. Thromb Haemost 2008; 100: 134–45.
Knöfler R, Streif W. Strategies in Clinical and Laboratory Diagnosis of Inherited Platelet Function Disorders in Children. Transfus Med Hemother 2010; 37: 231–5.
Platton S, McCormick Á, Bukht M, Gurney D, Holding I, Moore GW. A multicenter study to evaluate automated platelet aggregometry on Sysmex CS-series coagulation analyzers preliminary findings. Res Pract Thromb Haemost 2018; 2: 778–89.
Lippi G, Mattiuzzi C. Project management in laboratory medicine. J Med Biochem 2019; 38: 401–6.
Zhou L, Schmaier AH. Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field. Am J Clin Pathol 2005; 123: 172–83.
Pai M, Wang G, Moffat KA, Liu Y, Seecharan J, Webert K, et al. Diagnostic usefulness of a lumi-aggregometer adenosine triphosphate release assay for the assessment of platelet function disorders. Am J Clin Pathol 2011; 136: 350–8.
Brunet JG, Iyer JK, Badin MS, Graf L, Moffat KA, Timleck M, et al. Electron microscopy examination of platelet whole mount preparations to quantitate platelet dense granule numbers: Implications for diagnosing suspected platelet function disorders due to dense granule deficiency. Int J Lab Hematol 2018; 40: 400–7.
Castilloux JF, Moffat KA, Liu Y, Seecharan J, Pai M, Hayward CPM. A prospective cohort study of light transmission platelet aggregometry for bleeding disorders: is testing native platelet-rich plasma non-inferior to testing platelet count adjusted samples? Thromb Haemost 2011; 106: 675–82.
Bonduel M, Frontroth JP, Hepner M, Sciuccati G, FeliúTorres A. Platelet aggregation and adenosine triphosphate release values in children and adults. J Thromb Haemost 2007; 5: 1782–3.
Hvas AM, Favaloro EJ. Platelet function testing in pediatric patients. Expert Rev Hematol 2017; 10: 281–8.
Ravn HB, Andreasen JB, Hvas AM. Does whole blood coagulation analysis reflect developmental haemostasis? Blood Coagul Fibrinolysis 2017; 28: 218–23.
Taylor Ml, Misso NLA, Stewart GA, Thompson PJ. The effect of varying doses of aspirin on human platelet activation induced by PAF, Collagen and arachidonic acid. Br J Clin Pharmac 1992; 33: 25–31.
Copyright (c) 2020 Alenka Trampuš Bakija, Janez Jazbec, Barbara Faganel Kotnik
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.